Haemonetics 4th Quarter and Fiscal 2019 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Haemonetics (HAE) Tops Q4 EPS by 6c, Offers Guidance, Approves $500M Buyback
May 7, 2019 6:16 AM EDTHaemonetics (NYSE: HAE) reported Q4 EPS of $0.61, $0.06 better than the analyst estimate of $0.55. Revenue for the quarter came in at $249.3 million versus the consensus estimate of $250.63 million.
GUIDANCE:
Haemonetics sees FY2020 EPS of $2.80-$3.00, versus the consensus of $2.89.
SHARE REPURCHASE PROGRAM The Company announced that its Board of Directors recently authorized the repurchase of... More
